| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | - | - | 179.274 | 243.733 | 201.677 |
| Total Income - EUR | - | - | - | - | - | - | - | 179.274 | 243.940 | 204.336 |
| Total Expenses - EUR | - | - | - | - | - | - | - | 1.606 | 62.808 | 13.793 |
| Gross Profit/Loss - EUR | - | - | - | - | - | - | - | 177.669 | 181.132 | 190.543 |
| Net Profit/Loss - EUR | - | - | - | - | - | - | - | 176.079 | 178.695 | 161.238 |
| Employees | - | - | - | - | - | - | - | 1 | 1 | 0 |
Check the financial reports for the company - Medicine2You S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | - | - | 0 | 5.732 | 0 |
| Current Assets | - | - | - | - | - | - | - | 178.344 | 183.628 | 162.434 |
| Inventories | - | - | - | - | - | - | - | 208 | 0 | 0 |
| Receivables | - | - | - | - | - | - | - | 0 | 43.948 | 161.477 |
| Cash | - | - | - | - | - | - | - | 178.135 | 139.680 | 957 |
| Shareholders Funds | - | - | - | - | - | - | - | 176.119 | 183.760 | 161.279 |
| Social Capital | - | - | - | - | - | - | - | 41 | 40 | 40 |
| Debts | - | - | - | - | - | - | - | 2.224 | 5.600 | 1.155 |
| Income in Advance | - | - | - | - | - | - | - | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8623
|
|||||||||
Comments - Medicine2You S.r.l.